| | |
| | |
Stat |
Members: 3643 Articles: 2'479'597 Articles rated: 2609
19 March 2024 |
|
| | | |
|
Article overview
| |
|
Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine | C C Tsai
; K E Follis
; A Sabo
; T W Beck
; R F Grant
; N Bischofberger
; R E Benveniste
; R Black
; | Date: |
17 Nov 1995 | Journal: | Science, 270 (5239), 1197-9 | Abstract: | The efficacy of pre- and postexposure treatment with the antiviral compound (R)-9-(2-phosphonylmethoxypropyl)adenine (PMPA) was tested against simian immunodeficiency virus (SIV) in macaques as a model for human immunodeficiency virus (HIV). PMPA was administered subcutaneously once daily beginning either 48 hours before, 4 hours after, or 24 hours after virus inoculation. Treatment continued for 4 weeks and the virologic, immunologic, and clinical status of the macaques was monitored for up to 56 weeks. PMPA prevented SIV infection in all macaques without toxicity, whereas all control macaques became infected. These results suggest a potential role for PMPA prophylaxis against early HIV infection in cases of known exposure. | Source: | PubMed, pmid7502044 | Services: | Forum | Review | Favorites |
|
|
No review found.
Did you like this article?
Note: answers to reviews or questions about the article must be posted in the forum section.
Authors are not allowed to review their own article. They can use the forum section.
browser claudebot
|
| |
|
|
|
| News, job offers and information for researchers and scientists:
| |